J&J booster slashes Omicron hospitalizations: study

A booster dose of Johnson & Johnson Inc's single-dose COVID-19 vaccine was 84% effective at preventing hospitalization in South African healthcare workers who became infected as the Omicron variant spread, researchers said on Thursday. Olivia Chan reports.